Unmanipulated haploidentical bone marrow transplantation and posttransplantation cyclophosphamide for hematologic malignancies after myeloablative conditioning AM Raiola, A Dominietto, A Ghiso, C Di Grazia, T Lamparelli, F Gualandi, ... Biology of Blood and Marrow Transplantation 19 (1), 117-122, 2013 | 392 | 2013 |
Unmanipulated haploidentical transplants compared with other alternative donors and matched sibling grafts AM Raiola, A Dominietto, C di Grazia, T Lamparelli, F Gualandi, A Ibatici, ... Biology of Blood and Marrow Transplantation 20 (10), 1573-1579, 2014 | 327 | 2014 |
Direct intrabone transplant of unrelated cord-blood cells in acute leukaemia: a phase I/II study F Frassoni, F Gualandi, M Podestà, AM Raiola, A Ibatici, G Piaggio, ... The Lancet Oncology 9 (9), 831-839, 2008 | 314 | 2008 |
Blood stream infections in allogeneic hematopoietic stem cell transplant recipients: reemergence of Gram-negative rods and increasing antibiotic resistance M Mikulska, V Del Bono, AM Raiola, B Bruno, F Gualandi, D Occhini, ... Biology of Blood and Marrow Transplantation 15 (1), 47-53, 2009 | 257 | 2009 |
Unmanipulated haploidentical BMT following non-myeloablative conditioning and post-transplantation CY for advanced Hodgkin’s lymphoma A Raiola, A Dominietto, R Varaldo, A Ghiso, F Galaverna, S Bramanti, ... Bone marrow transplantation 49 (2), 190-194, 2014 | 184 | 2014 |
Allogeneic hemopoietic SCT for patients with primary myelofibrosis: a predictive transplant score based on transfusion requirement, spleen size and donor type A Bacigalupo, M Soraru, A Dominietto, S Pozzi, S Geroldi, MT Van Lint, ... Bone marrow transplantation 45 (3), 458-463, 2010 | 181 | 2010 |
Risk factors for invasive aspergillosis and related mortality in recipients of allogeneic SCT from alternative donors: an analysis of 306 patients M Mikulska, AM Raiola, B Bruno, E Furfaro, MT Van Lint, S Bregante, ... Bone marrow transplantation 44 (6), 361-370, 2009 | 181 | 2009 |
Incidence and outcome of invasive fungal diseases after allogeneic stem cell transplantation: a prospective study of the Gruppo Italiano Trapianto Midollo Osseo (GITMO) C Girmenia, AM Raiola, A Piciocchi, A Algarotti, M Stanzani, L Cudillo, ... Biology of Blood and Marrow Transplantation 20 (6), 872-880, 2014 | 179 | 2014 |
Factors influencing haematological recovery after allogeneic haemopoietic stem cell transplants: graft‐versus‐host disease, donor type, cytomegalovirus infections and cell dose A Dominietto, AM Raiola, MT Van Lint, T Lamparelli, F Gualandi, ... British journal of haematology 112 (1), 219-227, 2001 | 179 | 2001 |
Infections by carbapenem-resistant Klebsiella pneumoniae in SCT recipients: a nationwide retrospective survey from Italy C Girmenia, GM Rossolini, A Piciocchi, A Bertaina, G Pisapia, D Pastore, ... Bone marrow transplantation 50 (2), 282-288, 2015 | 175 | 2015 |
Unmanipulated haploidentical bone marrow transplantation and post-transplant cyclophosphamide for hematologic malignanices following a myeloablative conditioning: an update A Bacigalupo, A Dominietto, A Ghiso, C Di Grazia, T Lamparelli, ... Bone marrow transplantation 50 (2), S37-S39, 2015 | 168 | 2015 |
Incidence, risk factors and outcome of pre-engraftment gram-negative bacteremia after allogeneic and autologous hematopoietic stem cell transplantation: an Italian prospective … C Girmenia, A Bertaina, A Piciocchi, K Perruccio, A Algarotti, A Busca, ... Clinical Infectious Diseases 65 (11), 1884-1896, 2017 | 140 | 2017 |
Piperacillin/tazobactam (TazocinTM) seems to be no longer responsible for false-positive results of the galactomannan assay M Mikulska, E Furfaro, V Del Bono, AM Raiola, S Ratto, A Bacigalupo, ... Journal of antimicrobial chemotherapy 67 (7), 1746-1748, 2012 | 140 | 2012 |
Boost of CD34+-selected peripheral blood cells without further conditioning in patients with poor graft function following allogeneic stem cell transplantation A Larocca, G Piaggio, M Podestà, A Pitto, B Bruno, C Di Grazia, ... haematologica 91 (7), 935-940, 2006 | 138 | 2006 |
Mortality after bloodstream infections in allogeneic haematopoietic stem cell transplant (HSCT) recipients M Mikulska, V Del Bono, P Bruzzi, AM Raiola, F Gualandi, MT Van Lint, ... Infection 40, 271-278, 2012 | 135 | 2012 |
Factors predicting response and graft-versus-host disease after donor lymphocyte infusions: a study on 593 infusions AM Raiola, MT Van Lint, M Valbonesi, T Lamparelli, F Gualandi, ... Bone marrow transplantation 31 (8), 687-693, 2003 | 128 | 2003 |
Reducing transplant-related mortality after allogeneic hematopoietic stem cell transplantation A Bacigalupo, MP Sormani, T Lamparelli, F Gualandi, D Occhini, ... Haematologica 89 (10), 1238-1247, 2004 | 124 | 2004 |
Female genital tract graft-versus-host disease following allogeneic bone marrow transplantation S Spinelli, S Chiodi, S Costantini, MT Van Lint, AM Raiola, GB Ravera, ... Haematologica 88 (10), 1163-1168, 2003 | 116 | 2003 |
Lymphocyte subsets recovery following allogeneic bone marrow transplantation (BMT): CD4+ cell count and transplant-related mortality M Berger, O Figari, B Bruno, A Raiola, A Dominietto, M Fiorone, ... Bone marrow transplantation 41 (1), 55-62, 2008 | 109 | 2008 |
Transplant-related mortality and long-term graft function are significantly influenced by cell dose in patients undergoing allogeneic marrow transplantation A Dominietto, T Lamparelli, AM Raiola, MT Van Lint, F Gualandi, ... Blood, The Journal of the American Society of Hematology 100 (12), 3930-3934, 2002 | 107 | 2002 |